SRL Ranbaxy appoints Puri as new CEO

New Delhi, July 28 (UNI) SRL Ranbaxy, India's largest pathology chain, today appointed Jasmeet S Puri as CEO of the company and its associate., Fortis Clinical Research Ltd.

''SRL Ranbaxy is a quality driven organisation and my objective will be to lead the company to set up higher benchmarks for the Indian pathology industry,'' Mr Puri said.

Company's promoter and director Shivender Mohan Singh said that Mr Puri's rich experience in national and international marketing and management will help expanding comapny's vast national network and international operations.

UNI DKS RA PM2039